A phase II trial of gemcitabine and S-1 therapy in patients with resected pancreatic cancer: Japanese study group of adjuvant therapy for pancreatic cancer (JSAP-03).
Hiroshi Ishii
No relevant relationships to disclose
Hideki Ueno
No relevant relationships to disclose
Tomoo Kosuge
No relevant relationships to disclose
Yutaka Matsuyama
No relevant relationships to disclose
Akio Saiura
No relevant relationships to disclose
Rintaro Koga
No relevant relationships to disclose
Yoshihiro Sakamoto
No relevant relationships to disclose
Kazuaki Shimada
No relevant relationships to disclose
Akimasa Nakao
No relevant relationships to disclose
Ryuichiro Doi
No relevant relationships to disclose
Masao Tanaka
No relevant relationships to disclose